Role of Platelet-Rich Plasma injection during Modified Radical Mastectomy

Abstract

Background: platelet-rich plasma (PRP) is a human plasma product enriched by platelets, growth factors, and fibrinogen with high hemostatic and healing properties. Objectives: The aim of this study was to evaluate the effect of autologous PRP on wound healing in women undergoing modified radical mastectomy (MRM). Patients and Methods: In this randomized and controlled trial, 100 females were admitted to El Sayed Galal hospital, Egypt from October of 2017 to August of 2018 for MRM. The patients were randomly assigned to two groups. The intervention group received PRP after surgery, whereas the control group received the usual care. All patients were evaluated at baseline, five days, and 2 weeks after surgery. The primary endpoint used the REEDA scale for assessing the changes in wound healing. The secondary outcome measures used were the Vancouver scar scale (VSS). All scale scores were analyzed using a repeated measures test for the variance. Results: At the end of the study, the PRP group showed a greater reduction in the edema ecchymosed discharge approximation (REEDA) score compared to the control group (85.5% reduction in the PRP group; 72% in the control group) (P < 0.001). Furthermore, patients treated with PRP experienced a 93% reduction in the VAS score at the end of follow-up, but the control group only observed a 79% reduction (P < 0.001). Conclusions: It seems that applying PRP is an effective therapeutic approach for wound healing, and faster wound healing is expected due to the presence of more platelets and growth factors.